Evidence map›Paper›PMID 42650930›Full record

ReviewDiagnostics (Basel, Switzerland)2026

Averting Potential Misinterpretations and Diagnostic Misapplications of Misleading Laboratory Results.

Adel A A Ismail

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Adel A A IsmailClinical Biochemistry and Chemical Endocrinology, Mid-Yorkshire and Leeds Teaching Hospitals, Wakefield WF2 6HL, UK.ORCID 0000-0002-5509-9269

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosis is a dynamic process, encompassing clinical presentation of pathophysiology, workup investigations and appropriate interpretations/integration of all data. Diagnostic accuracy is expected when based on multiple tests/investigations. However, when diagnosis is based on a single abnormal laboratory test, considered to be fundamental and deterministic, an early test's error could cascade and propagate, triggering unnecessary investigations, longer hospitalisation and possible diagnostic misapplications. Up to 70% of diagnoses involve laboratory tests. Immunologically based analyses (immunoassays) have two fundamental features: (a) inherently higher analytical error rate than other common routine tests such as U&E, LFT, bone profile, FBC, et cetera, and (b) universality, affecting measurements regardless of the analyte's nature or the immunoassay's provider. Averting potentially erroneous results necessitates a paradigm shift which can be made by (a) intuitive use of a statistical paradigm (Bayesian reasoning), which will be explained by a simple example and without equations, and (b) appropriate and more use of follow-up confirmatory tests when the test has consequences and potential diagnostic misapplications by using available tests in all hospital laboratories.

Indexed as

analytical errorsBayesianchaosdiagnostic misapplicationimmunoassay’s misinterpretation

Identifiers

PMID42650930
PMCPMC13512845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.